Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 167589 | 120.15 |
09:34 ET | 46120 | 120.06 |
09:36 ET | 52343 | 119.85 |
09:38 ET | 26889 | 119.5201 |
09:39 ET | 26433 | 120 |
09:41 ET | 50484 | 120.065 |
09:43 ET | 47921 | 120.86 |
09:45 ET | 20117 | 121.8974 |
09:48 ET | 25675 | 120.6985 |
09:50 ET | 32048 | 121.13 |
09:52 ET | 9548 | 121 |
09:54 ET | 12419 | 121.15 |
09:56 ET | 33124 | 120.11 |
09:57 ET | 40081 | 120.1 |
09:59 ET | 33234 | 120.285 |
10:01 ET | 37577 | 119.1 |
10:03 ET | 59556 | 119.28 |
10:06 ET | 31387 | 118.8064 |
10:08 ET | 66326 | 118.8 |
10:10 ET | 60105 | 118.94 |
10:12 ET | 35282 | 119.095 |
10:14 ET | 27977 | 119.02 |
10:15 ET | 29303 | 119 |
10:17 ET | 58986 | 119.37 |
10:19 ET | 31772 | 118.5701 |
10:21 ET | 26960 | 118.74 |
10:24 ET | 21831 | 118.775 |
10:26 ET | 53146 | 119.725 |
10:28 ET | 14714 | 119.265 |
10:30 ET | 22878 | 119.455 |
10:32 ET | 21569 | 119.47 |
10:33 ET | 29590 | 120.01 |
10:35 ET | 35750 | 120.1216 |
10:37 ET | 23939 | 120.01 |
10:39 ET | 13979 | 120.31 |
10:42 ET | 19912 | 119.94 |
10:44 ET | 16237 | 120.35 |
10:46 ET | 10072 | 120.24 |
10:48 ET | 19988 | 120.16 |
10:50 ET | 12246 | 120.4091 |
10:51 ET | 23414 | 120.51 |
10:53 ET | 10133 | 120.29 |
10:55 ET | 6325 | 120.0501 |
10:57 ET | 20387 | 119.75 |
11:00 ET | 18395 | 119.77 |
11:02 ET | 8551 | 119.845 |
11:04 ET | 14696 | 120.465 |
11:06 ET | 25838 | 120.09 |
11:08 ET | 7959 | 120.48 |
11:09 ET | 10036 | 120.65 |
11:11 ET | 16206 | 120.44 |
11:13 ET | 16985 | 121.02 |
11:15 ET | 21534 | 120.97 |
11:18 ET | 13678 | 121.35 |
11:20 ET | 18836 | 121.5 |
11:22 ET | 16580 | 121.305 |
11:24 ET | 36528 | 121.45 |
11:26 ET | 20799 | 121.69 |
11:27 ET | 7264 | 121.48 |
11:29 ET | 11156 | 121.37 |
11:31 ET | 7883 | 121.21 |
11:33 ET | 13533 | 121.54 |
11:36 ET | 9694 | 121.3 |
11:38 ET | 9929 | 121.32 |
11:40 ET | 11577 | 121.375 |
11:42 ET | 7097 | 121.4 |
11:44 ET | 13880 | 121.4 |
11:45 ET | 4980 | 121.52 |
11:47 ET | 4878 | 121.72 |
11:49 ET | 9428 | 121.44 |
11:51 ET | 4313 | 121.47 |
11:54 ET | 8689 | 121.385 |
11:56 ET | 13504 | 121.17 |
11:58 ET | 10596 | 121.4501 |
12:00 ET | 7567 | 121.39 |
12:02 ET | 9030 | 121.52 |
12:03 ET | 3906 | 121.44 |
12:05 ET | 7414 | 121.3412 |
12:07 ET | 4157 | 121.335 |
12:09 ET | 4348 | 121.34 |
12:12 ET | 8855 | 121.2 |
12:14 ET | 4998 | 121.175 |
12:16 ET | 4662 | 121.11 |
12:18 ET | 12073 | 120.94 |
12:20 ET | 11027 | 121.03 |
12:21 ET | 10507 | 121 |
12:23 ET | 2303 | 121.005 |
12:25 ET | 3223 | 121.045 |
12:27 ET | 4400 | 120.942 |
12:30 ET | 3369 | 120.92 |
12:32 ET | 6534 | 120.9298 |
12:34 ET | 14058 | 120.881 |
12:36 ET | 10521 | 120.885 |
12:38 ET | 5619 | 120.95 |
12:39 ET | 2406 | 120.89 |
12:41 ET | 7206 | 120.66 |
12:43 ET | 3621 | 120.66 |
12:45 ET | 5573 | 120.67 |
12:48 ET | 6000 | 121.01 |
12:50 ET | 2783 | 121.24 |
12:52 ET | 9997 | 121.15 |
12:54 ET | 6877 | 121.42 |
12:56 ET | 4202 | 121.3 |
12:57 ET | 2010 | 121.22 |
12:59 ET | 8798 | 120.875 |
01:01 ET | 3059 | 120.9451 |
01:03 ET | 3730 | 120.9301 |
01:06 ET | 3711 | 120.81 |
01:08 ET | 6716 | 120.68 |
01:10 ET | 3145 | 120.68 |
01:12 ET | 1500 | 120.725 |
01:14 ET | 3433 | 120.61 |
01:15 ET | 9214 | 120.68 |
01:17 ET | 6180 | 120.94 |
01:19 ET | 2896 | 120.82 |
01:21 ET | 2517 | 120.825 |
01:24 ET | 2639 | 121.1 |
01:26 ET | 3391 | 121 |
01:28 ET | 4497 | 120.895 |
01:30 ET | 11361 | 121.0725 |
01:32 ET | 6339 | 120.73 |
01:33 ET | 1747 | 120.76 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 52.7B | -7.7x | --- |
ICON PLC | 26.1B | 38.2x | +4.68% |
Biogen Inc | 32.5B | 28.4x | -18.14% |
Biontech SE | 20.0B | 159.0x | --- |
Grifols SA | 5.9B | 20.1x | --- |
Alnylam Pharmaceuticals Inc | 30.4B | -91.2x | --- |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $52.7B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.66 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -7.7x |
Price/Sales (TTM) | 10.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.